SEC Form 4 · accession 0001127602-18-000975
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd W. Garner
Officer — Executive Vice President & CFO
Period of report
Jan 2, 2018
Accepted (ET)
Jan 4, 2018 · 12:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options To Purchase Common StockF1 | $50.61 | Jan 2, 2018 | A | 48,000 | A | — | Jan 2, 2028 | Common Stock | 48,000 | 48,000 | D |
| Rsus (restricted Stock Units)F2 | $0.00 | Jan 2, 2018 | A | 8,000 | A | — | Jan 2, 2028 | Common Stock | 8,000 | 8,000 | D |
Explanation of responses
- F1Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018.
- F2Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018.